Impact of an Early Decrease in Systolic Blood Pressure on The Risk of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention

被引:6
|
作者
Li, Hualong [1 ]
Huang, Shuijin [2 ]
He, Yiting [3 ]
Liu, Yong [1 ]
Liu, Yuanhui [1 ]
Chen, Jiyan [1 ]
Zhou, Yingling [1 ]
Tan, Ning [1 ]
Duan, Chongyang [4 ]
Chen, Pingyan [4 ]
机构
[1] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangzhou First Peoples Hosp, Guangzhou, Guangdong, Peoples R China
[3] First Peoples Hosp Shunde, Shunde, Guangdong, Peoples R China
[4] Southern Med Univ, Sch Publ Hlth & Trop Med, Natl Clin Res Ctr Kidney Dis, Dept Biostat, Guangzhou, Guangdong, Peoples R China
来源
HEART LUNG AND CIRCULATION | 2016年 / 25卷 / 02期
关键词
Contrast-induced nephropathy; Systolic blood pressure; Haemodynamic instability; Percutaneous coronary intervention; DECOMPENSATED HEART-FAILURE; RENAL HEMODYNAMICS; SERUM CREATININE; MEDIA; AUTOREGULATION; PREDICTION; OUTCOMES;
D O I
10.1016/j.hlc.2015.07.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The early postprocedural period was thought to be the rush hour of contrast media excretion, causing rapid and prolonged renal hypoperfusion, which was the critical time window for contrast-induced nephropathy (CIN). Methods 349 consecutive patients were enrolled into the study. The relation between an early postprocedural decrease in systolic blood pressure (SBP) and the risk of CIN was assessed using multivariate logistic regression. Results A postprocedural decrease in SBP was observed in 63% of patients and CIN developed in 28 (8.0%) patients. The CIN group had a lower postprocedural SBP (114.5 +/- 13.5 vs. 123.7 +/- 15.6 mmHg, P = 0.003) and a greater postprocedural decrease in SBP (16.2 +/- 19.1 vs. 5.9 +/- 18.7 mmHg, P = 0.005) than the no-CIN group. ROC analysis revealed that the optimum cutoff value for the SBP decrease in detecting CIN was >10 mmHg (sensitivity 60.7%, specificity 59.5%, AUC = 0.66). Multivariate logistic regression analysis found that a postprocedural decrease in SBP >10 mmHg was a significant independent predictor of CIN (OR 2.368, 95% CI: 1.043-5.379, P = 0.039), after adjustment for other risk factors. Conclusion An early moderate postprocedural decrease in SBP may increase the risk of CIN in patients undergoing PCI.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 50 条
  • [41] USEFULNESS OF NGAL AND KIM-1 AS EARLY BIOMARKERS OF CONTRAST-INDUCED NEPHROPATHY AFTER PERCUTANEOUS CORONARY INTERVENTION
    Zbierska, K.
    Chrzan, I.
    Pankiw, O.
    Gackowski, A.
    CARDIOLOGY, 2015, 132 : 163 - 163
  • [42] Retrospective Analysis of Percutaneous Coronary Intervention (PCI) with Contrast-Induced Nephropathy
    Zhao, Xin
    Han, Yaling
    Wang, Xiaozeng
    Wang, Shouli
    Jing, Quanmin
    CIRCULATION, 2010, 122 (02) : E54 - E54
  • [43] Contrast-Induced Nephropathy Morbidity and Mortality Following Percutaneous Coronary Intervention
    Brown, Jeremiah R.
    Solomon, Richard J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (12): : 1763 - 1763
  • [44] Impact of transient or persistent contrast-induced nephropathy on long-term mortality after percutaneous coronary intervention
    Abe, M.
    Akao, M.
    Morimoto, T.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1063 - 1063
  • [45] Hypoalbuminemia and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
    Peng, Long
    Tang, Xixiang
    Luo, Yanting
    Liu, Jinlai
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C164 - C164
  • [46] Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention
    Marenzi, Giancarlo
    De Metrio, Monica
    Rubino, Mara
    Lauri, Gianfranco
    Cavallero, Annalisa
    Assanelli, Emilio
    Grazi, Marco
    Moltrasio, Marco
    Marana, Ivana
    Campodonico, Jeness
    Discacciati, Andrea
    Veglia, Fabrizio
    Bartorelli, Antonio L.
    AMERICAN HEART JOURNAL, 2010, 160 (06) : 1170 - 1177
  • [47] Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention
    Jurado Roman, A.
    Granda Nistal, C.
    Hernandez Hernandez, F.
    Garcia Tejada, J.
    Martin Asenjo, R.
    Parra Fuertes, J. J.
    Molina Martin De Nicolas, J. J.
    Rubio Alonso, B.
    Velazquez Martin, M. T.
    Albarran, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 132 - 132
  • [48] Prevention of Contrast-induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
    Pranata, Raymond
    Wahyudi, Dendi Puji
    CURRENT CARDIOLOGY REVIEWS, 2024, 20 (01) : 21 - 27
  • [49] Predictors of Contrast-Induced Nephropathy after Use of Nonionic Contrast Media during Percutaneous Coronary Intervention
    Park, Soo Hawn
    Jeong, Myung Ho
    Kim, In-Soo
    Kim, Jeong Hun
    Lee, Doo Hwan
    Park, In Cheol
    Oh, Kyung Soo
    Kim, Nam Yun
    Park, Jin Hee
    Lee, Jae Hun
    Jeong, Young Suk
    Park, Hyun A.
    Kim, Hyun Kuk
    Kim, Sung Soo
    Ko, Jum Suk
    Lee, Min Goo
    Park, Keun Ho
    Sim, Duo Sun
    Yoon, Nam Sik
    Yoon, Hyun Ju
    Park, Hyung Wook
    Hong, Young Joon
    Kim, Ju Han
    Ahm, Young Keun
    Cho, Jeong Gwan
    Park, Jong Chun
    Kang, Jung Chae
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 60B - 60B
  • [50] Relationship Between the Urine Flow Rate and Risk of Contrast-Induced Nephropathy After Emergent Percutaneous Coronary Intervention
    Liu, Yong
    Lin, Lixia
    Li, Yun
    Li, Hualong
    Wu, Deng-Xuan
    Zhao, Jian-bin
    Lian, Dan
    Zhou, Yingling
    Liu, Yuanhui
    Ye, Piao
    Ran, Peng
    Duan, Chongyang
    Chen, Shiqun
    Chen, Pingyan
    Xian, Ying
    Chen, Jiyan
    Tan, Ning
    MEDICINE, 2015, 94 (50)